Amgen, Inc. (NASDAQ:AMGN)

How Biotech and Big Pharma Have Upside Heading Into Earnings

Biotech and many of the so-called Big Pharma have been duds in 2019. Despite many FDA approvals and some powerful mergers and royalty deals, the political pressure around drug pricing ...
Read Full Story »

Top Analyst Upgrades and Downgrades: Agilent, Alphabet, Altria, Amazon, Boeing, Caterpillar, Chipotle, E*Trade, Gap, Snap, Twitter and More

Stocks were indicated to open marginally higher on Friday as earnings season is so far proving to be not as bad as many investors had modeled in for the third ...
Read Full Story »

Top Analyst Upgrades and Downgrades: Abbott Labs, CSX, IBM, Netflix, Occidental, Whiting, Amgen, Gilead, Merck, Pfizer and More

Stocks were indicated to open marginally higher on Thursday as the world appears to have better hopes for a Brexit framework out of Europe. Investors are having to grapple with ...
Read Full Story »

Short Sellers Hike Bets in Major Biotechs

The short interest data are out for the most recent settlement date, September 30. Generally speaking, companies within the biotech industry are considered a riskier group of stocks, with big ...
Read Full Story »

Major Biotechs Scare Off Short Sellers

The short interest data are out for the most recent settlement date, September 13. Generally speaking, companies within the biotech industry are considered a riskier group of stocks, with big ...
Read Full Story »

Top Analyst Upgrades and Downgrades: Alcoa, Amgen, Apache, Chewy, Clorox, Concho Resources, Disney, Edwards Lifesciences, Occidental and More

The futures traded somewhat lower Monday morning after comments over the trade dispute Friday by the U.S. president sent the market lower. With the third quarter almost in the books, ...
Read Full Story »

Major Biotechs Scare Off Short Sellers

The short interest data are out for the most recent settlement date, August 30. Generally speaking, companies within the biotech industry are considered a riskier group of stocks, with big ...
Read Full Story »

Amgen’s Lung Cancer Study Needs to Take a Breather

Amgen Inc. (NASDAQ: AMGN) shares dropped on Monday after the firm released additional data from its early-stage lung cancer study. Specifically this data is coming from the ongoing Phase 1 ...
Read Full Story »

Top Analyst Upgrades and Downgrades: Amgen, Bank of America, Box, Chico’s FAS, Microsoft, Netflix, NXP, StoneCo, Tiffany and More

Stocks were indicated to open higher by 1% after a spokesperson from China's Ministry of Commerce said that it is willing to resolve the trade war with a calm attitude. ...
Read Full Story »

7 Giant Mergers Transforming the Face of Corporate America

In the world of mergers and acquisitions, it seems that large corporations are willing to wheel whether the economy and the stock market are strong or weak. The reality is ...
Read Full Story »

Short Sellers Hike Their Bets in Biotech

The short interest data are out for the most recent settlement date, August 15. Generally speaking, companies within the biotech industry are considered a riskier group of stocks, with big ...
Read Full Story »

Top Analyst Upgrades and Downgrades: Amgen, BorgWarner, Chipotle, Cree, Dollar General, Exelon, PDC Energy, Verizon, Zynga and More

Monday's stock market rally was based on hope that the trade war will not get out of hand, as Friday's news flow and sell-off in stocks might have indicated. Stocks ...
Read Full Story »

Is Amgen Overpaying for Celgene’s Psoriasis Treatment?

Both Amgen Inc. (NASDAQ: AMGN) and Celgene Corp. (NASDAQ: CELG) shares made a handy gain on Monday after it was announced that the companies had made an agreement in relation ...
Read Full Story »

Top Analyst Upgrades and Downgrades: Amgen, Aramark, Chevron, Deere, Exxon, Hecla, Occidental, Urban Outfitters, Whiting and More

Stocks were very volatile in the prior week after the worst one-day sell-off of 2019, but a late-week recovery is being followed by broad gains on Monday as long-term Treasury ...
Read Full Story »

Friday’s Top Analyst Upgrades and Downgrades: Walmart, Nvidia, Amgen, Applied Materials, Alibaba, Intel, Merck and More

This has been a rough week for the broad markets, with the S&P 500 and Dow Jones industrial average each down about 3% on last look. What’s shocking is that ...
Read Full Story »